Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review

AIMS: With a prevalence of 16%, diabetes mellitus (DM) is one of the most frequent non‐communicable comorbidities of tuberculosis (TB). DM is a major risk factor for adverse TB outcomes and may require personalized TB drug dosing regimens. However, information on the inclusion of DM in TB drug trial...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Clin Pharmacol
Main Authors: Lutfiana, Nurul Cholifah, van Boven, Job F.M., Masoom Zubair, Muhammad Asim, Pena, Michelle J., Alffenaar, Jan‐Willem C.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Systematic Review and Meta‐analysis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6595305/
https://ncbi.nlm.nih.gov/pubmed/30908689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13935
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares